See more : Gelteq Limited Ordinary Shares (GELS) Income Statement Analysis – Financial Results
Complete financial analysis of Olympus Corporation (7733.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Olympus Corporation, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Redeia Corporación, S.A. (RED.MC) Income Statement Analysis – Financial Results
- Oldfields Holdings Limited (OLH.AX) Income Statement Analysis – Financial Results
- Lucky Minerals Inc. (LKY.V) Income Statement Analysis – Financial Results
- United States Cellular Corporation SR NT 64 (UZC) Income Statement Analysis – Financial Results
- Green Cross Health Limited (GXH.NZ) Income Statement Analysis – Financial Results
Olympus Corporation (7733.T)
About Olympus Corporation
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials and orthopedic equipment. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 936.21B | 881.92B | 868.87B | 730.54B | 797.41B | 793.86B | 786.50B | 748.05B | 804.58B | 764.67B | 713.29B | 743.85B | 848.55B | 847.11B | 883.09B | 980.80B | 1,128.88B | 1,061.79B | 978.13B | 813.54B | 633.62B | 564.34B | 528.42B | 466.70B | 428.65B |
| Cost of Revenue | 346.38B | 285.07B | 297.17B | 271.01B | 297.84B | 284.30B | 276.01B | 256.71B | 269.34B | 274.82B | 272.83B | 365.65B | 464.74B | 459.51B | 474.84B | 519.58B | 619.40B | 611.50B | 619.90B | 516.47B | 335.05B | 293.53B | 308.64B | 271.44B | 0.00 |
| Gross Profit | 589.83B | 596.85B | 571.70B | 459.53B | 499.57B | 509.57B | 510.48B | 491.34B | 535.24B | 489.85B | 440.46B | 378.20B | 383.81B | 387.59B | 408.24B | 461.22B | 509.48B | 450.28B | 358.23B | 297.07B | 298.57B | 270.81B | 219.78B | 195.26B | 428.65B |
| Gross Profit Ratio | 63.00% | 67.68% | 65.80% | 62.90% | 62.65% | 64.19% | 64.91% | 65.68% | 66.52% | 64.06% | 61.75% | 50.84% | 45.23% | 45.76% | 46.23% | 47.03% | 45.13% | 42.41% | 36.62% | 36.52% | 47.12% | 47.99% | 41.59% | 41.84% | 100.00% |
| Research & Development | 80.73B | 76.90B | 85.30B | 81.80B | 91.60B | 94.00B | 89.50B | 79.18B | 81.42B | 74.10B | 66.80B | 63.38B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 473.23B | 420.55B | 405.40B | 357.03B | 405.02B | 437.51B | 426.60B | 414.86B | 430.77B | 398.89B | 367.01B | 343.12B | 0.00 | 0.00 | 0.00 | 0.00 | 396.86B | 351.55B | 295.71B | 273.92B | 235.57B | 208.47B | 177.50B | 159.76B | 0.00 |
| Selling & Marketing | 0.00 | 15.45B | 15.17B | 11.75B | 21.50B | 27.75B | 26.02B | 30.09B | 40.95B | 42.91B | 41.89B | 39.95B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 473.23B | 420.55B | 405.40B | 357.03B | 405.02B | 437.51B | 426.60B | 414.86B | 430.77B | 398.89B | 367.01B | 343.12B | 0.00 | 0.00 | 0.00 | 0.00 | 396.86B | 351.55B | 295.71B | 273.92B | 235.57B | 208.47B | 177.50B | 159.76B | 0.00 |
| Other Expenses | 108.29B | 0.00 | 13.89B | 21.11B | 11.56B | 44.38B | 2.81B | -4.95B | -1.66B | -7.80B | -9.51B | -10.10B | -6.86B | -7.28B | -5.42B | -5.73B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 581.53B | 410.73B | 419.29B | 378.14B | 416.58B | 481.89B | 429.41B | 414.86B | 430.77B | 398.89B | 367.01B | 343.12B | 348.29B | 352.23B | 348.10B | 426.64B | 396.86B | 351.55B | 295.71B | 273.92B | 235.57B | 208.47B | 177.50B | 159.76B | 0.00 |
| Cost & Expenses | 892.61B | 695.81B | 716.46B | 649.15B | 714.43B | 766.18B | 705.42B | 671.56B | 700.11B | 673.71B | 639.84B | 708.77B | 813.03B | 811.75B | 822.94B | 946.22B | 1,016.25B | 963.06B | 915.60B | 790.39B | 570.63B | 502.00B | 486.13B | 431.21B | 0.00 |
| Interest Income | 2.37B | 3.86B | 1.36B | 1.19B | 1.94B | 2.18B | 2.69B | 774.00M | 1.09B | 732.00M | 1.07B | 1.05B | 931.00M | 894.00M | 1.12B | 2.42B | 3.20B | 0.00 | 780.00M | 350.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 10.31B | 8.18B | 5.38B | 6.37B | 7.61B | 10.35B | 7.05B | 7.61B | 7.89B | 8.92B | 11.47B | 13.94B | 14.03B | 12.74B | 12.41B | 16.19B | 11.18B | 11.26B | 9.80B | 6.63B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 65.94B | 66.74B | 64.62B | 59.94B | 68.31B | 58.67B | 52.91B | 54.29B | 49.78B | 50.64B | 46.31B | 43.58B | 46.07B | 48.80B | 58.27B | 146.26B | 45.60B | 38.27B | 32.70B | 29.76B | 24.25B | 16.86B | 23.70B | 18.25B | 0.00 |
| EBITDA | 107.97B | 238.83B | 233.17B | 160.81B | 158.29B | 119.18B | 136.63B | 125.09B | 154.24B | 142.35B | 119.75B | 76.67B | 49.42B | 79.12B | 141.89B | -5.05B | 154.12B | 124.42B | 95.22B | 52.91B | 87.25B | 79.20B | 65.98B | 53.74B | 428.65B |
| EBITDA Ratio | 11.53% | 29.16% | 25.31% | 19.59% | 19.28% | 11.23% | 17.37% | 16.45% | 18.47% | 17.21% | 15.24% | 9.20% | 8.95% | 9.56% | 13.11% | 18.44% | 14.20% | 14.15% | 10.99% | 8.04% | 13.76% | 14.95% | 13.02% | 12.55% | 100.00% |
| Operating Income | 43.60B | 186.61B | 153.90B | 81.99B | 83.47B | 28.28B | 81.03B | 76.49B | 104.46B | 90.96B | 73.45B | 35.08B | 35.52B | 35.36B | 60.15B | 34.59B | 112.62B | 98.73B | 62.52B | 23.15B | 63.00B | 62.35B | 42.28B | 35.50B | 428.65B |
| Operating Income Ratio | 4.66% | 21.16% | 17.71% | 11.22% | 10.47% | 3.56% | 10.30% | 10.22% | 12.98% | 11.90% | 10.30% | 4.72% | 4.19% | 4.17% | 6.81% | 3.53% | 9.98% | 9.30% | 6.39% | 2.85% | 9.94% | 11.05% | 8.00% | 7.61% | 100.00% |
| Total Other Income/Expenses | -7.74B | -4.32B | -4.49B | -5.18B | -7.93B | -8.16B | -7.22B | 10.49B | -33.66B | -82.03B | -57.02B | -15.94B | -45.01B | -18.44B | 26.06B | -125.89B | -18.01B | -25.15B | -19.34B | -17.18B | -2.80B | -19.35B | -21.84B | -13.88B | -428.65B |
| Income Before Tax | 35.85B | 182.29B | 149.87B | 76.81B | 77.80B | 20.12B | 76.67B | 81.69B | 70.80B | 8.93B | 16.43B | 19.14B | -9.50B | 22.76B | 86.20B | -91.30B | 94.61B | 73.58B | 43.40B | 5.97B | 60.20B | 42.99B | 20.44B | 21.61B | 0.00 |
| Income Before Tax Ratio | 3.83% | 20.67% | 17.25% | 10.51% | 9.76% | 2.53% | 9.75% | 10.92% | 8.80% | 1.17% | 2.30% | 2.57% | -1.12% | 2.69% | 9.76% | -9.31% | 8.38% | 6.93% | 4.44% | 0.73% | 9.50% | 7.62% | 3.87% | 4.63% | 0.00% |
| Income Tax Expense | 8.88B | 44.30B | 33.90B | 11.14B | 26.14B | 12.07B | 19.57B | 3.47B | 8.15B | 17.81B | 2.80B | 10.90B | 39.28B | 14.93B | 38.27B | 25.87B | 36.76B | 26.08B | 14.83B | 17.80B | 26.64B | 18.65B | 10.16B | 9.83B | -1.86B |
| Net Income | 242.57B | 143.43B | 115.74B | 12.92B | 51.67B | 8.15B | 57.06B | 78.19B | 62.59B | -8.74B | 13.63B | 8.02B | -48.99B | 7.38B | 47.76B | -114.81B | 57.97B | 47.80B | 28.56B | -11.83B | 33.56B | 24.35B | 10.28B | 11.79B | 1.86B |
| Net Income Ratio | 25.91% | 16.26% | 13.32% | 1.77% | 6.48% | 1.03% | 7.26% | 10.45% | 7.78% | -1.14% | 1.91% | 1.08% | -5.77% | 0.87% | 5.41% | -11.71% | 5.14% | 4.50% | 2.92% | -1.45% | 5.30% | 4.31% | 1.95% | 2.53% | 0.43% |
| EPS | 199.91 | 113.22 | 90.22 | 44.89 | 61.18 | 5.97 | 41.71 | 31.25 | 45.73 | -6.38 | 10.26 | 7.24 | -40.65 | 3.60 | 44.31 | -95.28 | 53.62 | 44.20 | 26.50 | -9.82 | 31.74 | 22.97 | 9.72 | 11.14 | 1.76 |
| EPS Diluted | 199.44 | 113.08 | 90.17 | 44.87 | 61.15 | 5.96 | 41.69 | 31.24 | 45.71 | -6.38 | 10.26 | 7.24 | -40.65 | 3.60 | 44.31 | -95.28 | 53.61 | 44.20 | 26.50 | -9.82 | 31.74 | 22.97 | 9.72 | 11.14 | 1.76 |
| Weighted Avg Shares Out | 1.21B | 1.27B | 1.28B | 1.29B | 1.31B | 1.37B | 1.37B | 1.37B | 1.37B | 1.37B | 1.33B | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B |
| Weighted Avg Shares Out (Dil) | 1.22B | 1.27B | 1.28B | 1.29B | 1.31B | 1.37B | 1.37B | 1.37B | 1.37B | 1.37B | 1.33B | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B | 1.20B |
Source: https://incomestatements.info
Category: Stock Reports